-
21
Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
Published 2024-12-01Subjects: “…respiratory syncytial virus…”
Get full text
Article -
22
A Cross-Study Biomarker Signature of Human Bronchial Epithelial Cells Infected with Respiratory Syncytial Virus
Published 2016-01-01“…Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in children, elderly, and immunocompromised individuals. …”
Get full text
Article -
23
Clinical Epidemiological Characteristics and Risk Factors for Severe Bronchiolitis Caused by Respiratory Syncytial Virus in Vietnamese Children
Published 2021-01-01“…The disease is caused by respiratory syncytial virus (RSV) infection, which can cause breathing difficulties and respiratory failure. …”
Get full text
Article -
24
Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
Published 2016-01-01“…In 1995, the European Society for Paediatric Infectious Diseases (ESPID) carried out a survey of its members to assess the variation in management of respiratory syncytial virus (RSV) bronchiolitis. The aim of the current study was to carry out a similar survey 20 years later to assess how the management had changed. …”
Get full text
Article -
25
Inpatient service utilization amongst infants diagnosed with Respiratory Syncytial Virus infection (RSV) in the United States.
Published 2025-01-01“…<h4>Introduction</h4>Respiratory syncytial virus (RSV) is the leading cause of hospitalization among US infants. …”
Get full text
Article -
26
Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice
Published 2022-09-01Subjects: “…respiratory syncytial virus…”
Get full text
Article -
27
Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in context
Published 2025-04-01“…Summary: Background: Respiratory syncytial virus (RSV) can cause severe disease, notably among infants, older adults, and individuals with comorbidities. …”
Get full text
Article -
28
Circulation of Respiratory Syncytial Virus (RSV) in Poland Between Seasons of 2009/2010 and 2022/2023 Based on SENTINEL System
Published 2025-01-01Subjects: Get full text
Article -
29
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
Published 2024-11-01Subjects: Get full text
Article -
30
Inhibition of NF-κB/IL-33/ST2 Axis Ameliorates Acute Bronchiolitis Induced by Respiratory Syncytial Virus
Published 2021-01-01“…Bronchiolitis is a common acute lower respiratory tract infectious disease in infants. Respiratory syncytial virus (RSV) infection is one of the main causes. …”
Get full text
Article -
31
-
32
Respiratory Syncytial Virus Nonstructural Protein 1 Promotes 5-Lipoxygenase via miR-19a-3p
Published 2022-01-01“…Background. Respiratory syncytial virus (RSV) infection can regulate the expression of a wide range of noncoding microRNAs (miRNAs), in which mir-19a-3p can participate in airway inflammatory response by regulating 5-lipoxygenase (5-LO) pathway. …”
Get full text
Article -
33
Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus in English Primary Care: Protocol for an Observational Study of Acute Respiratory Infection
Published 2025-01-01“… BackgroundThere are gaps in our understanding of the clinical characteristics and disease burden of the respiratory syncytial virus (RSV) among community-dwelling adults. …”
Get full text
Article -
34
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
Published 2025-02-01“…Abstract The Food and Drug Administration (FDA) has approved vaccines designed by GSK, Pfizer and Moderna to protect high-risk populations against respiratory syncytial virus (RSV). These vaccines employ the pre-fusion F (pre-F) protein as the immunogen. …”
Get full text
Article -
35
Impact of COVID-19 on testing, positive cases, patient characteristics, and hospital contacts for respiratory syncytial virus, influenza, and pneumococcus in Danish children
Published 2025-02-01“…Results: We observed a marked decrease in cases of respiratory syncytial virus, influenza, and pneumococcus disease during the lockdown period. …”
Get full text
Article -
36
-
37
Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus
Published 2025-01-01Subjects: “…respiratory syncytial virus…”
Get full text
Article -
38
Cross-sectional seroprevalence study of bovine herpesvirus 1, bovine respiratory syncytial virus, and parainfluenza virus 3 in cattle from Villavicencio, Colombia
Published 2025-01-01“…Many viruses are considered causative agents of BRDC, including bovine herpesvirus 1 (BoHV-1), bovine respiratory syncytial virus (BRSV), and parainfluenza virus 3 (PI-3). …”
Get full text
Article -
39
Clinical manifestations, para-clinical features and outcome of Iranian adults with respiratory syncytial virus (RSV) infection: a report from hospitalized patients
Published 2025-02-01Subjects: “…Respiratory syncytial virus…”
Get full text
Article -
40
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease
Published 2025-01-01“…Background: Respiratory syncytial virus (RSV) causes the most common type of severe lower respiratory tract infection worldwide, and the fusion (F) protein is a target for neutralizing antibodies and vaccine development. …”
Get full text
Article